Effects of Robot-assisted Gait Training in Patients Burn Injury on Lower Extremity

February 24, 2020 updated by: Hangang Sacred Heart Hospital

Effects of Robot-assisted Gait Training in Patients Burn Injury on Lower Extremity : a Randomized Controlled Trial

Gait enables individuals to move forward and is considered a natural skill. However, gait disturbances are very common in patients with burn injury. Major causes of functional impairment are pain and joint contractures. Recent studies focused on the application of robot-assisted gait training (RAGT). This study aimed to elucidate the efficacy and investigate the mechanism of motor recovery after RAGT on patients with lower extremity burn.

Study Overview

Detailed Description

This study aimed to elucidate the efficacy and investigate the mechanism of motor recovery after RAGT on patients with lower extremity burn.

20 patients with burn were randomly divided into 2 groups. RAGT group received RAGT 5 sessions per week at duration 30 minutes with 30 minutes conventional physical therapy in 12 weeks. SUBAR® (CRETEM, Korea) is a wearable robot with a footplate that assists patients to perform voluntary muscle movements. The conventional group underwent conventional physical therapy twice a day, 5 times a week in 12 weeks. Main outcomes were functional ambulatory category(FAC), 6 minutes walking test(6MWT), visual analogue scale(VAS), isometric forces of bilateral knee and ankle muscles, and foot pressure analysis before and after 12 weeks training.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yeong-deungpo-Dong
      • Seoul, Yeong-deungpo-Dong, Korea, Republic of, 150-719
        • Hangang Sacred Heart Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients with full or virtually full thickness involvement of >50% on the body surface area of the lower extremity
  • age > 18 years
  • with ≤1 functional ambulation category (FAC) score ≤ 3

Exclusion Criteria:

  • patients with cognitive disorders before burn
  • serious cardiac dysfunction
  • problems with weight bearing due to unstable fractures
  • body weight ≥100 kg
  • severe fixed contracture
  • skin disorders that could be worsened by RAGT and conventional rehabilitation
  • patients with severe pain who were unable to undergo conventional rehabilitation programs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robot assisted gait training
Robot assisted gait training(RAGT) group received RAGT 5 sessions per week at duration 30 minutes with 30 minutes conventional physical therapy in 12 weeks. SUBAR® (CRETEM, Korea) is a wearable robot with a footplate that assists patients to perform voluntary muscle movements.
SUBAR® (CRETEM, Korea) is a wearable robot with a footplate that assists patients to perform voluntary muscle movements. RAGT group received RAGT 5 sessions per week at duration 30 minutes with 30 minutes conventional physical therapy in 12 weeks.
Active Comparator: conventional physical training group
The conventional group underwent conventional physical therapy( even level gait training and range of motion exercises) twice a day, 5 times a week in 12 weeks.
even level gait training and range of motion exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the changes of functional ambulatory category
Time Frame: baseline, and after 12 weeks intervention
Scale 0 means that the patient cannot walk or can only walk with assistance of two people. Scale 5 means that the patient can walk independently. Higher scores mean a better outcome.
baseline, and after 12 weeks intervention
the changes of 6 minutes walking test
Time Frame: baseline, and after 12 weeks intervention
6MWT was performed in accordance with standardized guidelines, and the walking course was 20 m. Patients were instructed to walk as far as possible in 6 min. Higher scores mean a better outcome.
baseline, and after 12 weeks intervention
the changes of visual analogue scale
Time Frame: baseline, and after 12 weeks intervention
Visual analogue scale was used to rate the degree of subjective pain during gait movement: 0 points were assigned when no pain was noted, and unbearable pain was assigned 10 points. higher scores mean a worse outcome
baseline, and after 12 weeks intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the changes of active range of motion of flexion and extension
Time Frame: baseline, and after 12 weeks intervention
The active range of motion(ROM) of different joints was measured using a goniometer and an inclinometer with a standardized technique(hip joint)
baseline, and after 12 weeks intervention
the changes of active range of motion of flexion and extension
Time Frame: baseline, and after 12 weeks intervention
The active range of motion(ROM) of different joints was measured using a goniometer and an inclinometer with a standardized technique(knee joint)
baseline, and after 12 weeks intervention
the changes of active range of motion of dorsiflexion and plantarflexion
Time Frame: baseline, and after 12 weeks intervention
The active range of motion(ROM) of different joints was measured using a goniometer and an inclinometer with a standardized technique(ankle joint)
baseline, and after 12 weeks intervention
the changes of isometric forces of knee flexion and knee extension
Time Frame: baseline, and after 12 weeks intervention
Isometric knee extension and knee flexion muscle strength were measured by handheld dynamometer. Two measurements were taken using handheld dynamometer. Each trial lasted for 3-5 s, with 30 second rest period between trials. The higher of the two valid measurements was recorded.
baseline, and after 12 weeks intervention
the changes of isometric forces of ankle dorsiflexion and ankle plantarflexion
Time Frame: baseline, and after 12 weeks intervention
Isometric ankle dorsiflexion, and ankle plantar flexion muscle strength were measured by handheld dynamometer. Two measurements were taken using handheld dynamometer. Each trial lasted for 3-5 s, with 30 second rest period between trials. The higher of the two valid measurements was recorded.
baseline, and after 12 weeks intervention
the changes of gait symmetry using stride length
Time Frame: baseline, and after 12 weeks intervention
Stride is the equivalent of a gait cycle. The duration of a stride is the interval between two sequential initial floor contacts by the same limb. symmetry ratio is defined with affected side stride length/ non affected side stride length.
baseline, and after 12 weeks intervention
the changes of center of foot pressure pattern
Time Frame: baseline, and after 12 weeks intervention
center of foot pressure patten during a normal stride. longitudinal line analysis
baseline, and after 12 weeks intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 25, 2019

Primary Completion (Actual)

February 24, 2020

Study Completion (Actual)

February 24, 2020

Study Registration Dates

First Submitted

October 22, 2019

First Submitted That Met QC Criteria

February 20, 2020

First Posted (Actual)

February 24, 2020

Study Record Updates

Last Update Posted (Actual)

February 26, 2020

Last Update Submitted That Met QC Criteria

February 24, 2020

Last Verified

October 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burns

Clinical Trials on Robot assisted gait training

3
Subscribe